United States

Lonza Group AG (LONN.S)

LONN.S on Virt-X Level 1

21 Feb 2018
Change (% chg)

CHF-0.90 (-0.36%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

Lonza To Establish Cell- And Gene-Therapy Centers Of Excellence
Wednesday, 14 Feb 2018 01:00am EST 


Lonza ‍expands offerings for early phase biopharmaceutical drug development​
Thursday, 2 Nov 2017 10:48am EDT 

Nov 2 (Reuters) - Lonza Group Ag :Says ‍expands service offerings for early phase biopharmaceutical drug development​.  Full Article

Lonza says not planning to sell wood preservation business after fixes
Thursday, 26 Oct 2017 09:34am EDT 

Oct 26 (Reuters) - Lonza Group Ag :Says wood preservation business 'definitely not under a question mark at this time,' when asked if company would consider selling ‍​.Says wood preservation business performance 'dramatically' better than 3-4 years ago when company considered selling it‍​.  Full Article

Lonza says acquires Micro-Macinazione
Friday, 4 Aug 2017 01:09am EDT 

Aug 4 (Reuters) - Lonza Group Ag :Lonza acquires Micro-Macinazione to create the global leader in micronization capacity and capabilities.Says Micro-Macinazione, which had sales of around CHF 20 million in 2016, has 120 employees and is based in Monteggio, Switzerland.Says financial details of deal were not disclosed.  Full Article

Lonza H1 sales 15.1 percent up to CHF 2,323 million
Wednesday, 26 Jul 2017 12:30am EDT 

July 26 (Reuters) - Lonza Group AG - :Lonza delivers strong performance in first half 2017 and sets a strong foundation for continued attractive mid-term growth <<>>.H1 sales 15.1 percent up to CHF 2,323 million.H1 core EBIT 43.3 percent up to CHF 447 million.Confirms outlook for full-year 2017 on a Lonza-standalone basis.To continue its momentum in H2 2017.Mid-Term guidance until end of 2022 sales CHF 7.5 billion.Mid-Term guidance until end of 2022 core EBITDA margin 30 percent.Mid-Term guidance until end of 2022 core RONOA 35 percent.  Full Article

Lonza says received regulatory approval for Capsugel acquisition
Tuesday, 27 Jun 2017 01:30am EDT 

June 27 (Reuters) - Lonza Group Ag :* Says lonza has received all regulatory approvals to move forward with acquisition of Capsugel.  Full Article

Lonza aims to raise 2.25 billion Sfr with new rights offering
Tuesday, 25 Apr 2017 12:10pm EDT 

April 25 (Reuters) - Lonza Group Ag :Says determined the final terms of the capital increase by way of a rights offering.Says agm approved an ordinary capital increase by the issuance of up to 22,000,000 fully paid registered shares.Says board decided to offer 16,548,612 newly issued shares with a nominal value of chf 1.00 each at an offer price of chf 136.00 meaning gross proceeds of chf 2.251 billion.Says the nominal amount of lonza's issued share capital will be increased from currently chf 57,920,140 to chf 74,468,752..Says the rights exercise period is expected to start on 2 may 2017 and end on 10 may 2017, 12.00 noon.Says the first trading day as well as the settlement and delivery of the offered shares against payment of the offer price are expected to occur on or around 12 may 2017.  Full Article

Lonza Group says had strong Q1, upgrades outlook
Tuesday, 25 Apr 2017 01:00am EDT 

April 25 (Reuters) - Lonza Group AG :Says starts 2017 with outstanding Q1.Says strong start in Q1 paves way for double-digit organic sales growth for first half year.Says core ebit growth expected to be even stronger than sales for H1.Says lonza is upgrading its outlook for 2017. Outlook is on a Lonza standalone basis.Says sales growth upgraded from mid-single-digit growth to high-single-digit growth .Sees core EBITDA above CHF 1 billion.Says sees double-digit core ebit growth significantly above sales growth.Says sees core RONOA above 21.5%.  Full Article

Lonza Group raises 865 mln Sfr from bookbuilding, shares placed 173 Sfr per share
Wednesday, 1 Feb 2017 01:22am EST 

Lonza Group Ag says : successfully places 5.0 million new shares, raising gross proceeds of 865 million Sfr . the shares were placed at 173.00 Swiss francs per new share . new shares are expected to be listed and admitted to trading on the SIX Swiss Exchange on 3. February 2017 . Additionally, Lonza has entered into lock up undertakings ending on the later of (1) 180 days following the first day of trading of the new shares issued in the Placement and (2) if the additional equity issuance proceeds, as referenced in Lonza's announcement of the Capsugel acquisition on 15 December 2016, 90 days following the first day of trading of the shares issued in that equity issuance Further company coverage: [LONN.S] (Reporting By Zurich newsroom) ((zurich.newsroom@thomsonreuters.com; +41 58 306 7336;)).  Full Article

Bookrunner gives pricing guidance on Lonza Group offering
Tuesday, 31 Jan 2017 12:00pm EST 

Bookrunner: Lonza Group AG ABB: bookrunner says visibility on potential investor interest in excess of 70 pct the deal size, from a limited market sounding exercise . Lonza Group AG ABB: bookrunner says pricing guidance of CHF172 to market Further company coverage: [LONN.S] (Bengaluru Newsroom) ((+91 806 749 1136;)).  Full Article

BRIEF-Lonza To Establish Cell- And Gene-Therapy Centers Of Excellence

* LONZA TO ESTABLISH CELL- AND GENE-THERAPY CENTERS OF EXCELLENCE TO ACCELERATE GROWTH Source text for Eikon: Further company coverage: (Gdynia Newsroom)